Ardx stock news today rneerjt

Ardx stock news today

03.04.2021

Coty77528

Feb 04, 2020 · Today, we will study why Ardelyx is a promising pick for 2020.Company overview. Ardelyx, Inc. is a biopharmaceutical company, focused on the development and … Ardelyx Reports Fourth Quarter and Full Year 2019 ... Mar 06, 2020 · FREMONT, Calif., March 6, 2020 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019. Ardelyx (NASDAQ:ARDX) - Why Are Shares Of Ardelyx Ripping ... Sep 04, 2019 · Shares of Ardelyx Inc (NASDAQ: ARDX) were advancing strongly on above-average volume Tuesday following a clinical trial readout from the company. What Happened Ardelyx

Mar 03, 2020 · Ardelyx Inc stock is higher by 139.25% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives ARDX stock a score of 84 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 90. ARDX's rank also includes a long-term technical score of 89.

Nov 05, 2019 · ARDX, Ardelyx Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Ardelyx Inc Stock Quote: ARDX Stock News, Quotes, Analysis | Investors.com News - ARDX ARDX NEWS. Feb 21. 1. ARDX Welcomes New Vice President of Technology Services By Laurie Cox-Spangle | News. Norfolk, VA, February 21, 2019 – ARDX, a leading government healthcare management and technology consulting firm, welcomes Tuan Nguyen as Vice President of Technology Services. Today, ARDX announced that they were selected by the ARDX Stock Price and Chart — NASDAQ:ARDX — TradingView

ARDX's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

Ardelyx News | Markets Insider Ardelyx News: This is the News-site for the company Ardelyx on Markets Insider Ardelyx (ARDX) in Focus: Stock Moves 8.3% Higher. Zacks 202d. 6 Top Gainers In Healthcare Sector (ACAD, ARDX Exelixis, Inc. (EXEL) Latest Stock News & Headlines ... Get the latest Exelixis, Inc. (EXEL) stock news and headlines to help you in your trading and investing decisions.

Ardelyx, Inc. Common Stock (ARDX) News Headlines | Nasdaq

ARDX Stock Summary. ARDX's price/sales ratio is 144.75; that's higher than the P/S ratio of 98.23% of US stocks. As for revenue growth, note that ARDX's revenue has grown -93% over the past 12 months; that beats the revenue growth of merely 0.72% of US companies in our set. Ardelyx Inc Stock Quote: ARDX Stock News, Quotes, Analysis ...

Exelixis, Inc. (EXEL) Latest Stock News & Headlines ...

Ardelyx Inc (ARDX) Stock Adds 0.29% This Week; Should You ... Mar 03, 2020 · Ardelyx Inc stock is higher by 139.25% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives ARDX stock a score of 84 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 90. ARDX's rank also includes a long-term technical score of 89. Ardelyx: A Promising Cardiorenal Small Cap Pick For 2020 ... Feb 04, 2020 · Today, we will study why Ardelyx is a promising pick for 2020.Company overview. Ardelyx, Inc. is a biopharmaceutical company, focused on the development and … Ardelyx Reports Fourth Quarter and Full Year 2019 ... Mar 06, 2020 · FREMONT, Calif., March 6, 2020 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2019.